July 2021 - Page 32 of 41

FridayJul 09, 2021 10:19 am

QualityStocksNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation in William Blair Biotech Focus Conference

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, will be part of this year’s online William Blair Biotech Focus Conference. VTGN management will participate in a panel discussion titled “Updates in Neuropsych.” Key executives will also be available for one-on-one meetings throughout the virtual conference, which will be held July 15. The panel discussion is slated to begin at 9 a.m. PT. In the announcement, VTGN noted that the panel…

FridayJul 09, 2021 9:58 am

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) Shares Map Dynamics Update

Nextech AR Solutions (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a diversified leading provider of augmented reality (“AR”) experience technologies and services, has released updated information about Map Dynamics, the hybrid event and trade show mapping software platform that it recently acquired. According to the announcement, Map Dynamics has generated an estimated $500,000 since the acquisition and has also been named the Supporting Associate Organization of the Year by the Florida Society of Association Executives. “With the Map Dynamics acquisition we not only ended up with a great platform that has serviced 4.5 million visitors, but also almost 700 association…

FridayJul 09, 2021 9:32 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Notes European Expansion, IP Portfolio Updates, to Participate in Neuropsychiatry Virtual Summit

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, is increasing its focus and research activities in Europe. The company announced that it is working with several academic and clinical research organizations as part of those efforts, which include the transfer of its intellectual property assets to its recently formed wholly owned Ireland subsidiary. According to the announcement, Cybin will also continue building its IP portfolio of novel psychedelic compounds, delivery platforms and methods of use in psychiatric indications. The company noted that its growing portfolio of intellectual property includes 12 patent filings and four active…

ThursdayJul 08, 2021 1:22 pm

QualityStocksNewsBreaks – Asia Broadband Inc. (AABB) Featured in Recent Benzinga Article as Potential ‘Next Big Thing’

Asia Broadband (OTC: AABB),a resource company focused on the production, supply and sale of precious and base metals primarily to Asian markets, has been highlighted in a recent Benzinga article for making aggressive moves in the crypto world. The article called the company’s AABB Gold Token a “one-of-a-kind” because of its vertical integration of mine-to-token gold backing, which means that, unlike other gold-backed cryptos, AABB holds physical gold assets that back the token 100% from the mining production segment of its holding company. The article also noted that more than $1 million of tokens were sold in the first few…

ThursdayJul 08, 2021 1:00 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leveraging Similar Strategy as Leading Cannabis-Derived Compound Pharmaceutical Company

Jazz Pharmaceuticals’ acquisition of GW Pharma for $7.2 billion in February 2021 shows the massive potential of the drug development industry from naturally-derived compounds Tryp Therapeutics is following in the footsteps of GW with its innovative drug pipeline and the development of psilocybin-based compounds for the treatment of diseases with high unmet medical needs It is one of only a handful of companies moving into Phase 2a clinical trials with a psychedelic compound, and seeks to duplicate the success of GW As of 2020, the global biotech sector was valued at $753 billion. It is further projected to grow at…

ThursdayJul 08, 2021 12:47 pm

QualityStocksNewsBreaks – Healthy Extracts Inc. (HYEX) Announces Ultimate Brain Nutrients ACTIVATE, a Breakthrough Nutraceutical Formulation

Healthy Extracts (OTCQB: HYEX), a leading developer and manufacturer of science-forward, clinically proven, plant-based products for heart and brain health, has unveiled a game-changing nutraceutical formulation: Ultimate Brain Nutrients ACTIVATE(TM) (“UBN”). According to the company, clinical studies indicate that the proprietary formulation naturally increases key brain activity by as much as 46%. Other results from studies show that ACTIVATE significantly improves human cognitive behavior and mental focus by activating areas of the brain that are key in attention, memory, mood and quick reaction times. HYEX has devoted more than two decades in research on the formulation, which included approximately 100 clinical studies…

ThursdayJul 08, 2021 12:38 pm

Infobird Co., Ltd (NASDAQ: IFBD) and its Influence on China’s SaaS Market

SMEs account for about 60% of China’s production GDP However, they have a relatively low adoption of SaaS and automation tools Infobird, through innovation and education, is trying to rectify this issue By targeting these SMEs, it will be impacting the entire Chinese SaaS market, positioning it as a global leader As of 2019, the Chinese software-as-a-service SaaS market was estimated between $3.7 billion and $6 billion in value (https://ibn.fm/NBymg). That was just 6% less than the total value of the global SaaS market. This is great for the country. However, when compared to other nations such as the United…

ThursdayJul 08, 2021 12:06 pm

QualityStocksNewsBreaks – DSG Global Inc. (DSGT) Announces Plans for Automotive Division to Deliver Vehicles on Grander Scale

DSG Global (OTCQB: DSGT), an emerging global technology company with an array of interconnecting businesses in rapidly growing market sectors, together with its automotive division, Imperium Motor Corp., today announced preparation of vehicles for sales from partners Skywell Auto and Jonway Automotive Group in the coming months. “The company is finally in a position, with increasing production and inventory, regular shipments and proper lines of credit with the various manufacturers to begin delivering vehicles on a grander scale,” said Rick Curtis, CEO of Imperium Motors. “The current backlog is being processed and the company anticipates deliveries to individuals, fleets, dealers…

ThursdayJul 08, 2021 11:38 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive Results From its Recent Animal Study on the Effectiveness of its DehydraTECH Drug Delivery Technology

Lexaria Bioscience Corp. announced positive results from its VIRAL-A20-2 study This study showed strong gains in delivery of the DehydraTECH-enabled remdesivir and ebastine among animals The success of this study shows the potential and commercial viability of Lexaria’s DehydraTECH In June 2021, Lexaria Bioscience (NASDAQ: LEXX) announced positive results from its VIRAL-A20-2 study that evaluated the effectiveness of DehydraTECH-enabled remdesivir and ebastine among animals. The results were strongly positive and demonstrated greater effectiveness than in Lexaria’s first antiviral drug study reported in December 2000. The research was a tolerability and pharmacokinetic (“PK”) study involving four groups of 10 animals each.…

ThursdayJul 08, 2021 11:04 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Brings Cutting-Edge Tech to the Neurology Market

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has developed cutting-edge tech that bridges the widening gap in access to quality care. The company’s clinical-grade neurological devices, NeuroCap(TM) and NeuroEEG(TM), are portable, cost-efficient, easy-to-use, and allow for long-term monitoring. This technology will be part of a ketamine clinical study conducted by Ehave Inc. (OTC: EHVVF) to establish the statistical correlation between ketamine treatment and patient improvement. “Using BRSF’s technology, Ehave will be able to brain map the volunteer patients and show changes in the neuroplasticity of the areas impacted,” reads a recent article. “BRSF’s…

Site Search

Company Search

Month: July 2021